Data confirms ZimVie implants meet critical roughness criteria advantageous for long-term peri-implant healthPALM BEACH GARDENS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq ...
ZimVie (ZIMV) announced the publication of a detailed scientific study demonstrating the surface texture of ZimVie’s premium implants may help to lower the risk of peri-implant infections when ...
Summers Value Partners highlighted stocks like ZimVie Inc. (NASDAQ:ZIMV) in the fourth quarter 2024 investor letter. ZimVie Inc. (NASDAQ:ZIMV) engages in the production and distribution of ...
Barclays lowered the firm’s price target on ZimVie (ZIMV) to $15 from $16 and keeps an Underweight rating on the shares. The firm says its 2025 medical technology outlook “hinges heavily” on ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Hosted on MSN7mon
ZimVie jumps after report on buyout talks with South Korea’s OsstemShares of ZimVie (NASDAQ:ZIMV) climbed ~13% premarket Thursday after Bloomberg reported that South Korean dental implant maker Osstem is in advanced talks to acquire the U.S.-based MedTech firm.
ZimVie Inc. has announced the publication of a scientific study indicating that the surface texture of its premium dental implants may reduce the risk of peri-implant infections compared to other ...
Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. It operates through the Spine Products and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback